CPRiL

C23H24N8O4S

CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO

InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)

• CUDC-907
• Fimepinostat
• 1339928-25-4
CUDC907
CUDC 907
Fimepinostat [USAN]
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
PI3K/HDAC Inhibitor centn
3S9RX35S5X
N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide
FIMEPINOSTAT [INN]
FIMEPINOSTAT [WHO-DD]
PI3K/HDAC INHIBITOR CUDC-907
5-PYRIMIDINECARBOXAMIDE, N-HYDROXY-2-(((2-(6-METHOXY-3-PYRIDINYL)-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)METHYLAMINO)-
5-pyrimidinecarboxamide, N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-
N-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide
N-Hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide
fimepinostatum
N-HYDROXY-2-(((2-(6-METHOXYPYRIDIN-3-YL)-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)(METHYL)AMINO)PYRIMIDINE-5-CARBOXAMIDE
N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide
N-hydroxy-2-((2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno(3,2-d)pyrimidin-6-yl)methyl-methylamino)pyrimidine-5-carboxamide
PI3K/HDAC Inhibitor
CHEMBL3622533
UNII-3S9RX35S5X
MFCD22420823
Fimepinostat (USAN/INN)
Fimepinostat (CUDC-907)
MLS006010994
GTPL8952
SCHEMBL1284705